Farmakogenetik ve farmakogenetik: Bu neden klinik genetikçi ile ilgilidir?
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
DOI: 10.1034/j.1399-0004.1999.560401.xPMID: 10636440
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
DOI: 10.1034/j.1399-0004.1999.560401.xPMID: 10636440
Assessing olfaction in the Italian population: methodology and clinical application.
DOI: 10.1007/s100720050043PMID: 10933437
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.
DOI: 10.1136/jnnp.67.3.300PMID: 10449550
Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study. The Norwegian-Danish Study Group.
DOI: 10.1046/j.1468-1331.1999.650539.xPMID: 10457386
Different postural reaction patterns for expected and unexpected perturbations in patients with idiopathic Parkinson's disease and other parkinsonian syndromes.
DOI: 10.1046/j.1468-1331.1999.650549.xPMID: 10457387
Therapeutic and "dose-dependent" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease.
DOI: 10.1002/(sici)1097-4547(19990915)57:6<935::aid-jnr19>3.0.co;2-8PMID: 10467265
Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
DOI: 10.1111/j.1600-0404.1999.tb00732.xPMID: 10478579
Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.
DOI: 10.1056/nejm199909233411311PMID: 10498497
[The effect of thalamic stimulation on levodopa induced dyskinesias--evaluation of a new target: the center parafascicular median].
PMID: 10486844
Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group.
DOI: 10.1212/wnl.53.5.1012PMID: 10496260
Tremor suppression using functional electrical stimulation: a comparison between digital and analog controllers.
DOI: 10.1109/86.788474PMID: 10498383
COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet).
DOI: 10.1046/j.1365-2125.1999.00027.xPMID: 10510160
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.